What Do Analysts Think About UniQure (QURE)? [Yahoo! Finance]
uniQure N.V. - Ordinary Shares (QURE)
Last uniqure n.v. - ordinary shares earnings: 4/29 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
uniqure.com/investors-newsroom/overview.php
Company Research
Source: Yahoo! Finance
from $50 on December 11, keeping a Buy rating on the stock and stating that it “refreshed diligence” on several companies under its coverage in the biotechnology sector. The firm added that it made several estimate, model, and price target changes for a 2026 look ahead note for the sector. UniQure (NASDAQ:QURE) also received a rating update from Mizuho analyst Uy Ear on December 8, who lowered the price target to $33 from $60 while keeping an Outperform rating on the stock. The firm cited the lowering of its view of the company's probability of success and expected launch year for AMT-130 by one year. This followed UniQure's (NASDAQ:QURE) announcement on December 4 that it received the final meeting minutes from the FDA regarding the pre-Biologics License Application (BLA) meeting that was held on October 29 to discuss the application for AMT-130. AMT-130 is an investigational gene therapy for Huntington's disease (HD). Management reported that the FDA conveyed in the final meet
Show less
Read more
Impact Snapshot
Event Time:
QURE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
QURE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
QURE alerts
High impacting uniQure N.V. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
QURE
News
- Macquarie Healthcare Fund Q3 2025 Commentary [Seeking Alpha]Seeking Alpha
- QURE Investigation Notice: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the FirmPR Newswire
- UniQure (QURE) Stock Drop Looms as FDA Concern Over Huntington's Data Spurs Mizuho Downgrade and Delayed Launch [Yahoo! Finance]Yahoo! Finance
- QURE INVESTIGATION: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the FirmGlobeNewswire
- uniQure (NASDAQ:QURE) had its price target lowered by analysts at Stifel Nicolaus from $50.00 to $40.00. They now have a "buy" rating on the stock.MarketBeat
QURE
Earnings
- 11/10/25 - Miss
QURE
Sec Filings
- 12/4/25 - Form 8-K
- 11/14/25 - Form SCHEDULE
- 11/14/25 - Form SCHEDULE
- QURE's page on the SEC website